Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 5/20 | 0.40 |
| ▸ | JAK2 | O60674 | 1/20 | 0.39 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.39 |
| ▸ | ABL1 | P00519 | 1/20 | 0.39 |
| ▸ | EGFR | P00533 | 1/20 | 0.39 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.39 |
| ▸ | LCK | P06239 | 1/20 | 0.39 |
| ▸ | CDK1 | P06493 | 1/20 | 0.39 |
| ▸ | CSF1R | P07333 | 1/20 | 0.39 |
| ▸ | LYN | P07948 | 1/20 | 0.39 |
| ▸ | RET | P07949 | 1/20 | 0.39 |
| ▸ | KIT | P10721 | 1/20 | 0.39 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10023404 | 0.89 | KDM4E (0.46) | ADORA2AKDM4EALDH1A1LMNANPSR1 | |
| SCHEMBL10041645 | 0.89 | KDM4E (0.44) | ADORA2AKDM4EALDH1A1LMNANPSR1 | |
| SCHEMBL10023343 | 0.85 | HPGD (0.51) | ADORA2AKDM4EALDH1A1LMNAHPGD | |
| SCHEMBL10023279 | 0.85 | KDM4E (0.44) | ADORA2AKDM4EALDH1A1LMNANPSR1 | |
| SCHEMBL10023277 | 0.85 | KDM4E (0.46) | ADORA2AKDM4EALDH1A1LMNANPSR1 | |
| SCHEMBL10023469 | 0.85 | ACACA (0.43) | ADORA2AKDM4EALDH1A1LMNANPSR1 | |
| SCHEMBL10023405 | 0.84 | ADORA2A (0.42) | ADORA2AKDM4EALDH1A1LMNANPSR1 | |
| SCHEMBL10023275 | 0.84 | KDM4E (0.45) | ADORA2AKDM4EALDH1A1LMNANPSR1 | |
| SCHEMBL10023745 | 0.84 | ADORA2A (0.39) | ADORA2AKDM4EALDH1A1LMNANPSR1 | |
| SCHEMBL10023635 | 0.83 | ADORA2A (0.43) | ADORA2AKDM4EALDH1A1LMNANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2311826-B1 | NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | LG CHEMICAL LTD (KR) | 2017-05-24 | — | — | EP | disclosed |
| US-9349964-B2 | Organic light emitting diode and manufacturing method thereof | LG CHEM, LTD. (KR) | 2016-05-24 | — | — | US | disclosed |
| US-9139562-B2 | Nitrogen-containing heterocyclic compound and organic electronic device using the same | LG CHEM, LTD. (KR) | 2015-09-22 | — | — | US | disclosed |
| EP-2570412-A1 | Novel nitrogen-containing heterocyclic compound and organic electronic device using the same | LG Chem, Ltd. (KR) | 2013-03-20 | — | — | EP | disclosed |
| US-8368062-B2 | Nitrogen-containing heterocyclic compound and organic electronic device using the same | LG CHEM, LTD. (KR) | 2013-02-05 | — | — | US | disclosed |
| WO-2012087067-A9 | ORGANIC LIGHT-EMITTING DEVICE AND METHOD FOR MANUFACTURING SAME | 주식회사 엘지화학 (KR) | 2012-09-07 | — | — | WO | disclosed |
| US-20120193612-A1 | ORGANIC LIGHT EMITTING DIODE AND MANUFACTURING METHOD THEREOF | LG CHEM, LTD. (KR) | 2012-08-02 | — | — | US | disclosed |
| WO-2012087067-A2 | ORGANIC LIGHT-EMITTING DEVICE AND METHOD FOR MANUFACTURING SAME | 주식회사 엘지화학 (KR) | 2012-06-28 | — | — | WO | disclosed |
| US-20120007069-A1 | NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | LG CHEM, LTD. (KR) | 2012-01-12 | — | — | US | disclosed |
| US-20110127513-A1 | NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | LG CHEM, LTD. (KR) | 2011-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120007069-A1 | NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | VDAC2, VDAC1, VDAC3 | ADORA2A 3232/4885KDM4E 382/4885ALDH1A1 2949/4885 |
| US-20110127513-A1 | NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | VDAC2, VDAC1, VDAC3 | ADORA2A 3232/4885KDM4E 382/4885ALDH1A1 2949/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.